Genomes and Genes
- Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practiceLaurent Becquemont
Pharmacology Department, Faculte de Medecine Paris Sud, Universite Paris Sud, Le Kremlin Bicetre, France
Eur J Clin Pharmacol 64:953-60. 2008..Ongoing prospective randomised trials will ascertain definitive answer over the coming years...
- Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipientsLina Quteineh
Pharmacology Department, Pierre et Marie Curie University, Saint Antoine University Hospital, Paris, France
Basic Clin Pharmacol Toxicol 103:546-52. 2008..Screening for this single nucleotide polymorphism before the transplantation might be helpful for the selection of adequate initial daily dose and to achieve the desired immunosuppression...
- SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipientsHugues Michelon
Pharmacology Department, Univ Paris Sud, Bicetre University Hospital, Le Kremlin, Bicetre, France
Pharmacogenomics 11:1703-13. 2010..This study aimed to determine the influence of gene candidates on mycophenolic acid (MPA) response during the first year of renal transplantation...
- Pharmacogenetics of acenocoumarol pharmacodynamicsSandrine Morin
Pharmacology Department, Saint Antoine University Hospital, Paris, France
Clin Pharmacol Ther 75:403-14. 2004..The aim of this study was to investigate the respective contribution of the different cytochrome P450 (CYP) 2C9 genetic polymorphisms to the interindividual variability of acenocoumarol pharmacodynamic response...
- Impact of VKORC1 haplotypes on long-term graft function in kidney transplantationLina Quteineh
Pharmacology Department, Pierre and Marie Curie University, Saint Antoine University Hospital, Paris, France
Transplantation 86:779-83. 2008..We aimed to study the effect of VKORC1 haplotypes on long-term graft function in a cohort of kidney transplant recipients...
- Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphismPhilippe Durand
Pediatric Intensive Care Department, Assistance Publique Hopitaux de Paris, Bicetre Hospital, Le Kremlin Bicetre, France
Pharmacogenomics 14:1017-25. 2013..Little information is available regarding the influence of CYP3A5 genetic polymorphisms on tacrolimus dose requirement in pediatric liver transplantation...
- Thyroid-stimulating hormone, 5-HTTLPR genotype, and antidepressant response in depressed womenFlorence Gressier
Department of Psychiatry, Univ Paris Sud, Assistance Publique Hopitaux de Paris, Bicetre University Hospital, Le Kremlin Bicetre, France
Psychiatr Genet 21:253-6. 2011..Further research is needed to understand the underlying mechanism explaining interactions between sex, TSH, and serotonergic function...
- Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapyCeline Verstuyft
Pharmacology Department, Saint Antoine Hospital, Pierre et Marie Curie University, Paris VI, Assistance Publique Hopitaux de Paris, 37 rue de Chaligny 75012 Paris, France
AIDS 19:2127-31. 2005..The relationship between MDR1 single nucleotide polymorphisms (SNP) and the pharmacokinetic or pharmacodynamic responses to protease inhibitors has been recently challenged...
- Pharmacogenomics of adverse drug reactions: practical applications and perspectivesLaurent Becquemont
Universite Paris Sud, Clinical Pharmacology Department, APHP, Hopital Bicetre, 78 rue du General Leclerc, 94275 Le Kremlin Bicetre, France
Pharmacogenomics 10:961-9. 2009..Parallel development of pharmacogenomic bed tests will certainly establish genetically-based prescriptions in routine medical practice...
- The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndromeCorinne Miceli-Richard
INSERM U 802, Universite Paris Sud 11, Le Kremlin Bicetre, France
Arthritis Rheum 60:1991-7. 2009....
- Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindioneKarine Lacut
EA 3878, Universite de Bretagne Occidentale, F 29609 Brest, France
Br J Clin Pharmacol 73:428-36. 2012..The role of these variants in fluindione response is unknown. Our aim was to assess whether genetic factors contribute to the variability in the response to fluindione...
- Environmental and genetic factors associated with morphine response in the postoperative periodLaurent Coulbault
Pharmacology Department, Saint Antoine University of Medicine, University Pierre et Marie Curie, Paris, France
Clin Pharmacol Ther 79:316-24. 2006..The aim of this study was to investigate the respective influence of genetic and nongenetic factors on morphine dose requirements and adverse effects after colorectal surgery...
- Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and PharmacogenomicsLaurent Becquemont
Univ Paris Sud, Faculty of Medicine Paris Sud, Pharmacology Department, Assistance Publique Hopitaux de Paris, Hopital Bicetre, Le Kremlin Bicetre, France
Pharmacogenomics 12:113-24. 2011..We hope that these practical recommendations will help physicians, biologists, scientists and other healthcare professionals to prescribe, perform and interpret these genetic tests...
- Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C>T in a Chinese and a Caucasian populationClaire Larramendy-Gozalo
Genetic Molecular, Pharmacogenetic and Hormonology Bicêtre University Hospital, University Paris Sud, Le Kremlin Bicetre, France
Basic Clin Pharmacol Toxicol 98:611-3. 2006
- Clinical relevance of pharmacogeneticsLaurent Becquemont
Pharmacology Department, Bicetre University Hospital, University Paris Sud, Assistance Publique, Hopitaux de Paris, Paris, France
Drug Metab Rev 35:277-85. 2003..To promote pharmacogenetics in routine medical practice, large prospective randomized trials are needed to demonstrate that pharmacogenetic orientated prescription can sometimes predict drug response without dramatic increase in costs...
- Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populationsJue Quin Yang
Pharmacology Department, Saint Antoine University Hospital University Pierre et Marie Curie Assistance Publique Hôpitaux de Paris, Paris, France
Fundam Clin Pharmacol 17:373-6. 2003..The low frequency of the CYP2C9*2 and CYP2C9*3 allelic variants in Chinese subjects does not justify their detection in clinical practice, unlike French Caucasians...